Objective Cardiovascular diseases (CVD) remain the leading cause of mortality globally, necessitating early risk ...
Against the odds, GSK has secured FDA approval for its multiple myeloma therapy Blenrep, three years after it was removed from sale. Anti-BCMA antibody-drug conjugate (ADC) Blenrep (belantamab ...
A Hybrid Machine Learning Framework for Early Diabetes Prediction in Sierra Leone Using Feature Selection and Soft-Voting Ensemble ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results